Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Completed

Phase 3 Results

Summary of Purpose

To determine if the combined incidence of nonfatal myocardial infarction and coronary heart disease death differs between diuretic-based and each of three alternative antihypertensive pharmacological treatments. Also, to determine, in a subset of this population, if lowering serum cholesterol with a HMG CoA reductase inhibitor in older adults reduces all-cause mortality compared to a control group receiving usual...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 July 2016.

1 Aug 1993 27 Oct 1999 1 Mar 2002 1 Mar 2002 1 Feb 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Purpose: Prevention

Contacts

  • Jackson T. Wright, Jr, MD, PhD Case Western Reserve University General Clinical Research Center Suite 7311, Horvitz Tower 11000 Euclid ave Cleveland, OH 44106

    jxw20@po.cwru.edu